| GTO ID | GTC0982 |
| Trial ID | ChiCTR2200058072 |
| Disease | Hematologic Cancer |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Quality of life and influencing factors of hematological malignancies treated with chimeric antigen receptor-T cell |
| Year | 2022 |
| Country | China |
| Company sponsor | The First Affiliated Hospital, Zhejiang University of Medicine |
| Cohort 1 | |||||||
|
|||||||